Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology (Q71671957)
Jump to navigation
Jump to search
scientific article published on 01 February 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology |
scientific article published on 01 February 1995 |
Statements
Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology (English)
K Schmiegelow
H Schrøder
G Gustafsson
J Kristinsson
A Glomstein
T Salmi
1 February 1995